VANDA PHARMACEUTICALS INC shareholders Q3 2023

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.

VANDA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
CAXTON ASSOCIATES LP 192,884$833,2590.12%
Palo Alto Investors LP 278,985$1,205,2150.11%
Y-Intercept (Hong Kong) Ltd 162,475$701,8920.07%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 633,079$2,734,9010.07%
GLOBEFLEX CAPITAL L P 96,331$416,1500.05%
XTX Topco Ltd 62,514$270,0600.05%
DARK FOREST CAPITAL MANAGEMENT LP 119,127$514,6290.04%
ACADIAN ASSET MANAGEMENT LLC 1,750,655$7,5590.03%
WINTON GROUP Ltd 87,493$377,9700.03%
Trexquant Investment LP 274,252$1,184,7690.03%
External links

This page lists VANDA PHARMACEUTICALS INC's shareholders in Q3 2023. To view VANDA PHARMACEUTICALS INC's shareholder history, click here.